Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

559 ARTÍCULOS , VIENDO DEL 496 AL 510

Research progress of plant-derived natural alkaloids in central nervous system diseases

Zhang Q, Jiang Q, Sa K, Liang J, Sun D, Li H, Chen L.

Phytother Res. 2023 Nov;37(11):4885-4907. doi: 10.1002/ptr.7955. Epub 2023 Jul 16.

Cholinesterase Inhibitors for Treatment of Psychotic Symptoms in Alzheimer Disease and Parkinson Disease: A Meta-analysis

d'Angremont E, Begemann MJH, van Laar T, Sommer IEC.

JAMA Neurol. 2023 Aug 1;80(8):813-823. doi: 10.1001/jamaneurol.2023.1835.

Melatonin Can Modulate Neurodegenerative Diseases by Regulating Endoplasmic Reticulum Stress

Yoo YM, Joo SS.

Int J Mol Sci. 2023 Jan 25;24(3):2381. doi: 10.3390/ijms24032381.

Recent Advancements in Nanomaterials: A Promising Way to Manage Neurodegenerative Disorders

Nguyen TT, Nguyen-Thi PT, Nguyen THA, Ho TT, Tran NM, Van Vo T, Van Vo G.

Mol Diagn Ther. 2023 Jul;27(4):457-473. doi: 10.1007/s40291-023-00654-1. Epub 2023 May 22.

Cognitive Interventions for Neurodegenerative Disease

Krellman JW, Mercuri G.

Curr Neurol Neurosci Rep. 2023 Sep;23(9):461-468. doi: 10.1007/s11910-023-01283-1. Epub 2023 Jul 10.

Differential Role of Active Compounds in Mitophagy and Related Neurodegenerative Diseases

Makarov M, Korkotian E.

Toxins (Basel). 2023 Mar 6;15(3):202. doi: 10.3390/toxins15030202.

Cracking Brain Diseases from Gut Microbes-Mediated Metabolites for Precise Treatment

Gong Y, Chen A, Zhang G, Shen Q, Zou L, Li J, Miao YB, Liu W.

Int J Biol Sci. 2023 Jun 4;19(10):2974-2998. doi: 10.7150/ijbs.85259. eCollection 2023.

The Neuropharmacological Evaluation of Seaweed: A Potential Therapeutic Source

Jannat K, Balakrishnan R, Han JH, Yu YJ, Kim GW, Choi DK.

Cells. 2023 Nov 18;12(22):2652. doi: 10.3390/cells12222652.

Impact of TRPV1 on Pathogenesis and Therapy of Neurodegenerative Diseases

Wang W, Sun T.

Molecules. 2023 Dec 28;29(1):181. doi: 10.3390/molecules29010181.

Targeting the central nervous system: From synthetic nanoparticles to extracellular vesicles-Focus on Alzheimer's and Parkinson's disease

Hernando S, Santos-Vizcaíno E, Igartua M, Hernandez RM.

Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2023 Sep-Oct;15(5):e1898. doi: 10.1002/wnan.1898. Epub 2023 May 8.

Traversing through the cell signaling pathways of neuroprotection by betanin: therapeutic relevance to Alzheimer's Disease and Parkinson's Disease

Phukan BC, Roy R, Paul R, Mazumder MK, Nath J, Bhattacharya P, Borah A.

Metab Brain Dis. 2023 Mar;38(3):805-817. doi: 10.1007/s11011-023-01177-8. Epub 2023 Feb 6.

Anti-amyloid potential of some phytochemicals against Aβ-peptide and α-synuclein, tau, prion, and Huntingtin protein

Jerom JP, Madhukumar S, Nair RH, Narayanan SP.

Drug Discov Today. 2023 Dec;28(12):103802. doi: 10.1016/j.drudis.2023.103802. Epub 2023 Oct 17.

Nanoparticle Mediated Gene Therapy: A Trailblazer Armament to Fight CNS Disorders

Annu, Rehman S, Nabi B, Sartaj A, Md S, Sahoo PK, Baboota S, Ali J.

Curr Med Chem. 2023;30(3):304-315. doi: 10.2174/0929867329666220105122318.

Antidiabetic agents as a novel treatment for Alzheimer's and Parkinson's disease

Nowell J, Blunt E, Gupta D, Edison P.

Ageing Res Rev. 2023 Aug;89:101979. doi: 10.1016/j.arr.2023.101979. Epub 2023 Jun 14.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias